Roquefort Therapeutics plc (LON:ROQ – Get Rating)’s share price shot up 1.8% during mid-day trading on Monday . The company traded as high as GBX 7.04 ($0.09) and last traded at GBX 7 ($0.09). 167,602 shares changed hands during trading, an increase of 27% from the average session volume of 131,834 shares. The stock had previously closed at GBX 6.88 ($0.08).
Roquefort Therapeutics Price Performance
The firm has a fifty day simple moving average of GBX 7.04 and a 200 day simple moving average of GBX 7.60. The company has a market cap of £9.04 million and a price-to-earnings ratio of -2.50.
About Roquefort Therapeutics
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Featured Stories
- Pinterest is the Social Commerce Platform to Watch in 2023
- Is Walgreens Boots Alliance Earnings Miss Good For Investors?
- Why Warner Bros Discovery Is the S&P’s Hottest Stock
- 4 High-Yield Dividend Kings For 2023
- Will 2023 be a Good Year for Goodyear Tire Stock?
Receive News & Ratings for Roquefort Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roquefort Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
